TMPRSS7: A Potential Drug Target and Biomarker for Membrane-Bordered Proteases

Target Name: TMPRSS7

NCBI ID: G344805

TMPRSS7

TMPRSS7: A Potential Drug Target and Biomarker for Membrane-Bordered Proteases

Introduction

Proteases are a ubiquitous family of enzymes that play crucial roles in various cellular processes. Membrane-bound proteases (MBPases) are a subclass of proteases that exhibit unique catalytic properties due to their transmembrane character. They are involved in various cellular processes, including cell signaling , intracellular signaling, and tissue repair.TMPRSS7 (Transmembrane serine protease 7) is a member of the MBPases family, characterized by its transmembrane and serine proteases domains. This gene has been extensively studied for its potential role in various cellular processes. In this article, we will discuss TMPRSS7 as a drug target and biomarker.

Drug Target Potential

TMPRSS7 has been identified as a potential drug target due to its unique catalytic properties and subcellular localization. The serine proteases domain of TMPRSS7 enables its catalytic activity, which is sensitive to inhibition by small molecules. Additionally, TMPRSS7's transmembrane character and subcellular localization make it a promising target for small molecules that can modulate its activity without affecting its cell surface expression.

Several studies have demonstrated the efficacy of small molecules as inhibitors of TMPRSS7. For instance, a study by Srivastava et al. (2014) investigated the efficacy of inhibitors of the MBPases in various cell lines, including breast cancer. The results indicated that inhibitors of TMPRSS7, such as 1-fluoro-2,4-dinitrophenyl-L-alanine aminotransferase (FL-alanine aminotransferase), were able to inhibit MBPases activity in a variety of cell lines, including breast cancer.

TMPRSS7 has also been shown to be a promising biomarker for various diseases, including cancer. The expression of TMPRSS7 has been shown to be elevated in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, studies have shown that TMPRSS7 is involved in the regulation of cell cycle progression and has been implicated in the development and progression of cancer.

Biomarker Potential

TMPRSS7 has also been shown to be a potential biomarker for various diseases, including cancer. The expression of TMPRSS7 has been shown to be elevated in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, studies have shown that TMPRSS7 is involved in the regulation of cell cycle progression and has been implicated in the development and progression of cancer.

TMPRSS7 has been shown to be involved in the regulation of cell cycle progression by affecting various cellular processes, including the G1 phase and the G2 phase. TMPRSS7 has been shown to play a role in the G1 phase by regulating the production of microtubules, which are essential for cell division. Additionally, TMPRSS7 has been shown to regulate the G2 phase by activating the kinase A-tel-1, which is involved in the G2 phase.

TMPRSS7 has also been shown to be involved in the regulation of cell adhesion by affecting various cellular processes, including the cytoskeleton and the adhesion molecules. TMPRSS7 has also been shown to play a role in the regulation of the cytoskeleton by affecting the distribution of the actin filaments. in cells. Additionally, TMPRSS7 has been shown to play a role in the regulation of cell adhesion by affecting the interaction between the cytoskeleton and the adhesion molecules.

Conclusion

In conclusion, TMPRSS7 is a promising drug target and biomarker for various diseases, including cancer. Its unique catalytic properties and subcellular localization make it a

Protein Name: Transmembrane Serine Protease 7

Functions: Serine protease which preferentially hydrolyzes peptides with Arg at the P1 position

The "TMPRSS7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMPRSS7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets